AI Article Synopsis

  • The study investigates the benefits of intensity modulated proton therapy (IMPT) for left-sided breast cancer patients, focusing on reducing radiation exposure to the heart and coronary artery during treatment.
  • The research involved creating and comparing four treatment plans for 20 patients, analyzing the radiation doses received by critical organs and the tumor target.
  • Findings show that IMPT offers significant dose reductions to the heart and coronary area, even without breath-holding, suggesting it is most beneficial for patients at high risk of cardiac complications, despite its limited availability.

Article Abstract

Purpose: In left-sided breast cancer radiotherapy, tangential intensity modulated radiotherapy combined with breath-hold enables a dose reduction to the heart and left anterior descending (LAD) coronary artery. Aim of this study was to investigate the added value of intensity modulated proton therapy (IMPT) with regard to decreasing the radiation dose to these structures.

Methods: In this comparative planning study, four treatment plans were generated in 20 patients: an IMPT plan and a tangential IMRT plan, both with breath-hold and free-breathing. At least 97 % of the target volume had to be covered by at least 95 % of the prescribed dose in all cases. Specifically with respect to the heart, the LAD, and the target volumes, we analyzed the maximum doses, the mean doses, and the volumes receiving 5-30 Gy.

Results: As compared to IMRT, IMPT resulted in significant dose reductions to the heart and LAD-region even without breath-hold. In the majority of the IMPT cases, a reduction to almost zero to the heart and LAD-region was obtained. IMPT treatment plans yielded the lowest dose to the lungs.

Conclusions: With IMPT the dose to the heart and LAD-region could be significantly decreased compared to tangential IMRT with breath-hold. The clinical relevance should be assessed individually based on the baseline risk of cardiac complications in combination with the dose to organs at risk. However, as IMPT for breast cancer is currently not widely available, IMPT should be reserved for patients remaining at high risk for major coronary events.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196139PMC
http://dx.doi.org/10.1007/s10549-014-3149-6DOI Listing

Publication Analysis

Top Keywords

reduction heart
12
breast cancer
12
heart lad-region
12
dose
8
intensity modulated
8
impt
8
treatment plans
8
tangential imrt
8
impt dose
8
heart
6

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!